Natco files compulsory license request; USA approves temporary patent waiver; Ericsson and Samsung settle dispute and more
Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve…